Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma
This study has been terminated.
(Slow accrual)
Sponsor:
Comprehensive Cancer Center of Wake Forest University
Collaborator:
Information provided by (Responsible Party):
Comprehensive Cancer Center of Wake Forest University
ClinicalTrials.gov Identifier:
NCT01103375
First received: April 13, 2010
Last updated: February 27, 2013
Last verified: February 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | June 2013 |
| Primary Completion Date: | January 2013 (Final data collection date for primary outcome measure) |